Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUNA: Pyrimethamine and Valproic Acid for HIV Latency
NCT03525730Phase 2Completed
- Sponsor
- Erasmus MC
- Start
- Apr 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pyrimethamine in human immunodeficiency virus infection (HIV), sponsored by Erasmus MC. Started Apr 2018; status: completed.
02
Drugs
pyrimethamine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03525730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03525730.